Literature DB >> 31362887

Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma.

Y Li1, C Yan2, S Weng3, Z Shi2, H Sun2, J Chen2, X Xu2, R Ye2, J Hong4.   

Abstract

AIM: To determine whether texture analysis of preoperative magnetic resonance imaging (MRI) images could be used to detect Ki67 expression, a widely used cell proliferation marker in hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: In total, 83 patients were included, 25 with low Ki67 (Ki67 ≤10%) HCC expression and 58 with high Ki67 (Ki67 ≥10%) HCC expression as demonstrated by retrospective surgical evaluation. All patients were examined using a 3 T MRI unit with one standard protocol. The region of interest was drawn manually by one radiologist. Texture analysis included histogram, co-occurrence matrix, run-length matrix, gradient, auto-regressive model, and wavelet transform features as calculated by MaZda (version 4.6; quantitative texture analysis software). The features reduced by the Fisher, probability of classification error, and average correlation coefficient (POE+ACC), mutual information were used to select the features that predicted Ki67 proliferation status with highest accuracy and then using the B11 program for data analysis and classification.
RESULTS: The misclassification rate of the principal component analysis (PCA) in the hepatobiliary phase (HBP), T2-weighted imaging (T2WI), arterial phase (AP), and portal vein phase (PVP) was 36/83 (43.37%), 35/82 (42.68%), 40/83 (48.19%), and 34/83 (40.96%), respectively. The misclassification of the linear discriminant analysis in HBP, T2WI, AP, and PVP phase was 13/83 (15.66%), 21/82 (25.61%), 9/83 (10.84%), and 8/83 (9.64%), respectively. The misclassification of the nonlinear discriminant analysis in HBP, T2WI, AP, and PVP phase was 7/83 (8.43%), 6/82 (7.32%), 5/83 (6.02%), and 7/83 (8.43%), respectively.
CONCLUSIONS: Texture analysis of HBP, AP, and PVP were helpful for predicting Ki67 expression and may provide a less-invasive method to investigate critical histopathology markers for HCC.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31362887     DOI: 10.1016/j.crad.2019.06.024

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

1.  Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study.

Authors:  Mengmeng Feng; Mengchao Zhang; Yuanqing Liu; Nan Jiang; Qian Meng; Jia Wang; Ziyun Yao; Wenjuan Gan; Hui Dai
Journal:  BMC Cancer       Date:  2020-06-30       Impact factor: 4.430

Review 2.  Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Emily Harding-Theobald; Jeremy Louissaint; Bharat Maraj; Edward Cuaresma; Whitney Townsend; Mishal Mendiratta-Lala; Amit G Singal; Grace L Su; Anna S Lok; Neehar D Parikh
Journal:  Aliment Pharmacol Ther       Date:  2021-08-12       Impact factor: 9.524

3.  Radiomic analysis based on multi-phase magnetic resonance imaging to predict preoperatively microvascular invasion in hepatocellular carcinoma.

Authors:  Yue-Ming Li; Yue-Min Zhu; Lan-Mei Gao; Ze-Wen Han; Xiao-Jie Chen; Chuan Yan; Rong-Ping Ye; Dai-Rong Cao
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

Review 4.  Quantitative magnetic resonance imaging for focal liver lesions: bridging the gap between research and clinical practice.

Authors:  Roberto Cannella; Riccardo Sartoris; Jules Grégory; Lorenzo Garzelli; Valérie Vilgrain; Maxime Ronot; Marco Dioguardi Burgio
Journal:  Br J Radiol       Date:  2021-05-14       Impact factor: 3.629

5.  Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery.

Authors:  Yu-Fei Zhao; Xiu Xiong; Kai Chen; Wei Tang; Xu Yang; Zheng-Rong Shi
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 6.  Progress of MRI Radiomics in Hepatocellular Carcinoma.

Authors:  Xue-Qin Gong; Yun-Yun Tao; Yao-Kun Wu; Ning Liu; Xi Yu; Ran Wang; Jing Zheng; Nian Liu; Xiao-Hua Huang; Jing-Dong Li; Gang Yang; Xiao-Qin Wei; Lin Yang; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

7.  Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images.

Authors:  Zheng Ye; Likun Cao; Yi Wei; Jie Chen; Zhen Zhang; Shan Yao; Ting Duan; Bin Song
Journal:  Ann Transl Med       Date:  2020-02

8.  Evaluation of Multiple Prognostic Factors of Hepatocellular Carcinoma with Intra-Voxel Incoherent Motions Imaging by Extracting the Histogram Metrics.

Authors:  Gaofeng Shi; Xue Han; Qi Wang; Yan Ding; Hui Liu; Yunfei Zhang; Yongming Dai
Journal:  Cancer Manag Res       Date:  2020-07-20       Impact factor: 3.989

9.  Quantitative analysis of multiphase magnetic resonance images may assist prediction of histopathological grade of small hepatocellular carcinoma.

Authors:  Shuping Weng; Xuru Xu; Yueming Li; Chuan Yan; Jianwei Chen; Rongping Ye; Yuemin Zhu; Liting Wen; Jinsheng Hong
Journal:  Ann Transl Med       Date:  2020-08

10.  Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Chunhong Hu
Journal:  BMC Med Imaging       Date:  2021-06-15       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.